Our findings revealed that CD4+ TRMs were more highly expressed in the lungs of RSV-infected asthma model mice than in those of circulating CD4+ memory T cells, including CD4+ TEMs and CD4+ TCMs, for at least 6 weeks in BALB/c mice. The gene discussed is CD4; the disease is asthma.